Madam Deputy Speaker, I think I have wound up enough people this evening, but I thank all Members, from all parties, who have spoken in tonight’s debate. It is my view that the contributions of Members of this House have brought about a real and material change in what is going on at the NIHR, Cancer Research UK and other organisations, because we are watching and speaking out. We need to do that, because if we do not, they will simply continue along the same path, and we cannot allow that to happen.

Question put and agreed to.

Resolved,

That this House
notes that survival rates for brain tumours have seen little improvement in decades and that brain tumours remain the biggest cancer killer of children and adults under 40; expresses concern at the limited availability of clinical trials for brain tumour patients;
calls on the Government to set out a clear plan to increase survival rates, including accelerating access to clinical trials and innovative therapies;
further calls on the Government to support the expansion of tissue freezing and storage to enable research and the development of new treatments;
and also calls on the Government to ensure the timely deployment of the research funding committed in 2018 through the National Institute for Health and Care Research for brain tumour research.